You Are Here: Home > Investor Relations > Directors


Ewan Phillips

Chief Executive

Ewan has been Chief Executive since 2009.  Ewan joined the Company as Finance Director in 2001 and was Managing Director of the UK subsidiary from 2005. He has served on a number of Association of British Healthcare Industries committees including joint industry/government working groups. Ewan’s background is in corporate finance.

Jonathan Shaw

Finance Director

Jonathan Shaw has spent the majority of his career working at either director or senior manager level in professional accounting and auditing firms most recently with Grant Thornton UK LLP in London and including PricewaterhouseCoopers LLP in Southampton where he was Deltex Medical’s senior audit manager for nearly four years. During his career Mr Shaw has undertaken a number of secondments to industry or government and spent almost three years at the Financial Reporting Council, the UK’s independent regulator responsible for promoting high quality corporate governance and reporting to foster investment.


Nigel Keen


Nigel has been involved with Deltex Medical since 1988 and Chairman since 1996. He is also Chairman of the following companies; Syncona Partners LLP, a company funded by The Wellcome Trust which was founded in 2012 and operates as an evergreen investment company; Oxford University Innovation Ltd, the technology transfer group for Oxford University; and Oxford Academic Health Science Network, a new entity established by the National Health Service in England to align the interests of patients in its region with academia, industry and the healthcare system. His career has encompassed venture capital, industry and banking. He has a degree in engineering from Cambridge University, is a Fellow of the Institute of Chartered Accountants, a Fellow of the Institute of Engineering and Technology and has been involved in the formation and development of high technology businesses for more than thirty years. Nigel is Chairman of the Deltex Medical’s Remuneration Committee.

Professor Sir Duncan Nichol

Duncan has been an influential figure in the provision of acute health services in the UK throughout his career. He worked for the NHS for nearly 30 years in a number of senior management roles and was Chief Executive from 1989 to 1994. Duncan was the Deputy Chairman of the Christie NHS Foundation Trust from 2008 to 2012 and is currently Chairman of the Countess of Chester NHS Foundation Trust. Duncan is also currently a Non-executive Chairman of Synergy Health plc, a provider of healthcare support services to the NHS and the first Chairman of the UK Academy for Healthcare Science.

Julian Cazalet

Julian joined the Board in April 2008 and is the Chairman of the Audit Committee. He was until 2007 a Managing Director — Corporate Finance of JPMorgan Cazenove. After graduating in Economics from Cambridge, he qualified as a Chartered Accountant before joining Cazenove in 1973. He became a Partner in 1978. From 1989 he worked in Corporate Finance, firstly in Equity Capital Markets and subsequently advising listed companies. He is Chairman of Herald Investment Trust plc and a Director of Charles Taylor plc, and of a number of charities. Julian is Chairman of the Audit Committee.

Mark Wippell

Mark, formerly a Partner with Allen & Overy LLP, has significant experience advising international companies on their strategic transactions. His experience includes public and private M&A, business reorganisations, complex joint ventures, demergers and securities offerings. Mark is qualified as a lawyer in both the UK and the US and has worked extensively with North American based businesses internationally.

Christopher Jones

Chris joined the board in June 2015 and has over 25 years’ of experience in the healthcare industry both in the UK and importantly throughout the USA. He is currently Chairman of Mologic Ltd, Non-Executive Director of MediSieve Ltd and Non- Executive Director of Health Enterprise East. Having spent 10 years as CEO Medical device companies GlySure Ltd and Tensys Medical Inc., he brings valuable experience to Deltex which will be of great assistance to the company as it seeks to capitalise on its leading position in ODM in the USA.